Microbot Medical (MBOT) EBT (2010 - 2026)

Microbot Medical (MBOT) has reported EBT for 17 consecutive years, with -$3.7 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, EBT fell 25.85% year-over-year to -$3.7 million; the trailing twelve-month figure through Mar 2026 stood at -$14.2 million (down 18.54% YoY), and the FY2025 full-year result was -$13.8 million, down 18.26% from the prior year.
• EBT eased to -$3.7 million in Q1 2026 per MBOT's latest filing, from -$3.5 million in the prior quarter.
• Across five years, EBT topped out at -$2.0 million in Q4 2023 and bottomed at -$3.7 million in Q1 2026.
• Historically, EBT has averaged -$3.0 million across 5 years, with a median of -$3.2 million in 2022.
• The sharpest annual moves came in 2023 and 2024: EBT soared 34.9% in 2023, then sank 66.19% in 2024.
• Over 5 years, EBT stood at -$3.0 million in 2022, then jumped by 31.81% to -$2.0 million in 2023, then sank by 66.19% to -$3.4 million in 2024, then retreated by 2.12% to -$3.5 million in 2025, then decreased by 5.98% to -$3.7 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$3.7 million, -$3.5 million, and -$3.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.